Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis - PubMed (original) (raw)

Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis

Marthe Moldes et al. Biochem J. 2003.

Abstract

The Wnt/beta-catenin signalling pathway appears to operate to maintain the undifferentiated state of preadipocytes by inhibiting adipogenic gene expression. To define the mechanisms regulating suppression of Wnt/beta-catenin signalling, we analysed the beta-catenin expression in response to activation of transcription factors that regulate adipogenesis. The results show an extensive down-regulation of nuclear beta-catenin that occurs during the first few days of differentiation of 3T3-L1 preadipocytes and coincides with the induction of the adipogenic transcription factors, C/EBPbeta (CCAAT-enhancer-binding protein) and PPARgamma (peroxisome-proliferator-activated receptor). To assess the role of each of these factors in this process, we conditionally overexpressed C/EBPbeta in Swiss mouse fibroblasts using the TET-off system. Abundant expression of C/EBPbeta alone had minimal effect on beta-catenin expression, whereas expression of C/EBPbeta, in the presence of dexamethasone, induced PPARgamma expression and caused a measurable decrease in beta-catenin. In addition, exposure of cells expressing both C/EBPbeta and PPARgamma to a potent PPARgamma ligand resulted in an even greater decrease in beta-catenin by mechanisms that involve the proteasome. Our studies also suggest a reciprocal relationship between PPARgamma activity and beta-catenin expression, since ectopic production of Wnt-1 in preadipocytes blocked the induction of PPARgamma gene expression. Moreover, by suppressing beta-catenin expression, ectopic expression of PPARgamma in Wnt-1-expressing preadipocytes rescued the block in adipogenesis after their exposure to the PPARgamma ligand, troglitazone.

PubMed Disclaimer

Similar articles

• Regulation of Wnt/β-catenin signaling by CCAAT/enhancer binding protein β during adipogenesis.
  Chung SS, Lee JS, Kim M, Ahn BY, Jung HS, Lee HM, Kim JW, Park KS. Chung SS, et al. Obesity (Silver Spring). 2012 Mar;20(3):482-7. doi: 10.1038/oby.2011.212. Epub 2011 Jul 14. Obesity (Silver Spring). 2012. PMID: 21760632
• A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes.
  Hamm JK, Park BH, Farmer SR. Hamm JK, et al. J Biol Chem. 2001 May 25;276(21):18464-71. doi: 10.1074/jbc.M100797200. Epub 2001 Feb 27. J Biol Chem. 2001. PMID: 11279134
• Regulation of PPARgamma activity during adipogenesis.
  Farmer SR. Farmer SR. Int J Obes (Lond). 2005 Mar;29 Suppl 1:S13-6. doi: 10.1038/sj.ijo.0802907. Int J Obes (Lond). 2005. PMID: 15711576 Review.
• Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity.
  Feng S, Reuss L, Wang Y. Feng S, et al. Molecules. 2016 Sep 23;21(10):1278. doi: 10.3390/molecules21101278. Molecules. 2016. PMID: 27669202 Free PMC article. Review.

Cited by

• The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.
  Sadie-Van Gijsen H, Crowther NJ, Hough FS, Ferris WF. Sadie-Van Gijsen H, et al. Cell Mol Life Sci. 2013 Jul;70(13):2331-49. doi: 10.1007/s00018-012-1211-2. Epub 2012 Nov 21. Cell Mol Life Sci. 2013. PMID: 23178849 Free PMC article. Review.
• Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.
  Watt J, Schlezinger JJ. Watt J, et al. Toxicology. 2015 May 4;331:66-77. doi: 10.1016/j.tox.2015.03.006. Epub 2015 Mar 14. Toxicology. 2015. PMID: 25777084 Free PMC article.
• PPAR gamma, bioactive lipids, and cancer progression.
  Robbins GT, Nie D. Robbins GT, et al. Front Biosci (Landmark Ed). 2012 Jan 1;17(5):1816-34. doi: 10.2741/4021. Front Biosci (Landmark Ed). 2012. PMID: 22201838 Free PMC article. Review.
• The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
  Abdelkarim M, Caron S, Duhem C, Prawitt J, Dumont J, Lucas A, Bouchaert E, Briand O, Brozek J, Kuipers F, Fievet C, Cariou B, Staels B. Abdelkarim M, et al. J Biol Chem. 2010 Nov 19;285(47):36759-67. doi: 10.1074/jbc.M110.166231. Epub 2010 Sep 17. J Biol Chem. 2010. PMID: 20851881 Free PMC article.
• Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism.
  Styner M, Sen B, Xie Z, Case N, Rubin J. Styner M, et al. J Cell Biochem. 2010 Nov 1;111(4):1042-50. doi: 10.1002/jcb.22793. J Cell Biochem. 2010. PMID: 20672310 Free PMC article.

References

1. 1. J Biol Chem. 2002 May 31;277(22):19649-57 - PubMed
2. 1. J Nutr. 2002 May;132(5):904-10 - PubMed
3. 1. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6 - PubMed
4. 1. Cell. 1975 May;5(1):19-27 - PubMed
5. 1. Genes Dev. 1991 Sep;5(9):1538-52 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database